Fellowbook News

Lipid nanoparticles carry gene-editing cancer drugs past tumor defenses

As they grow, solid tumors surround themselves with a thick, hard-to-penetrate wall of molecular defenses. Getting drugs past that barricade is notoriously difficult. Now, scientists at UT Southwestern have developed nanoparticles that can break down the physical barriers around tumors to reach cancer cells. Once inside, the nanoparticles release their payload: a gene editing system that alters DNA inside the tumor, blocking its growth and activating the immune system.

The new nanoparticles, described in Nature Nanotechnology, effectively stopped the growth and spread of ovarian and liver tumors in mice. The system offers a new path forward for the use of the gene editing tool known as CRISPR-Cas9 in cancer treatment, said study leader Daniel Siegwart, Ph.D., Associate Professor of Biochemistry at UT Southwestern… Continue reading.

More News from Daniel J. Siegwart, Ph.D.

LNPs Deliver Gene-Editing Tools Directly to Lung Stem Cells, Achieve Long-Lasting Correction
When it comes to challenges in the genome editing space, all eyes are on delivery. Efficient editing of cells directly in an organism (rather than ex vivo) and targeting of relevant stem cells is still a hurdle to be cleared in the progress of genetic...
Dr. Daniel Siegwart Elected to the 2022 Class of the AIMBE College of Fellows
WASHINGTON, D.C. — The American Institute for Medical and Biological Engineering (AIMBE) has announced the election of Daniel J. Siegwart, Ph.D., Associate Professor, Dept. of Biochemistry, University of Texas Southwestern Medical Center to its College...